Tag Archives: drug company marketing

The Baker boss responds to the alarm bells

April 29, 2009 – 6:00 pm

Garry Jennings. director of the Baker IDI Heart and Diabetes Institute, has sent in the following response to concerns raised at Croakey and elsewhere, with a link to a question and answer document on the Institute’s website:
“We thank everyone for their comments. This is an innovative donation arrangement so we are not surprised at the [...]

By Croakey | Posted in Crikey register of influence, Media-related issues, conflicts of interest, health & medical marketing, health ethics | Also tagged , , , | Comments (2)

Some responses to the deal between Sanofi-Aventis and the Baker

April 29, 2009 – 10:57 am

Dr Ken Harvey, Adjunct Senior Research Fellow, School of Public Health, La Trobe University, has written a long comment on my post below, and it is well worth a read. He also advises that he is putting in a complaint to Medicines Australia about the Sanofi-Aventis campaign.
Meanwhile, here are some other comments on the deal:
Dr [...]

By Croakey | Posted in Crikey register of influence, Media-related issues, conflicts of interest, health & medical marketing, health ethics | Also tagged , , , | Comments (0)

Who’s the loser with this clever drug company campaign?

April 28, 2009 – 6:30 pm

You’ve got to hand it to Sanofi-Aventis.
At the same time as the Vioxx case before the Federal Court is producing an alarming string of stories about the hazards of overly close ties between doctors and pharma (as an example, see this story in the Oz and this one in The Age), Sanofi-Aventis has enticed a [...]

By Croakey | Posted in Crikey register of influence, Media-related issues, conflicts of interest, health & medical marketing, health ethics | Also tagged , | Comments (2)